---
title: "Winrevair given US FDA approval for the treatment of pulmonary arterial hypertension"
date: "2024-03-28T12:31:36.000Z"
publishedDate: "28 mars 2024"
summary: "Merck has announced the US Food and Drug Administration (FDA) has approved sotatercept-csrk (Winrevair) for the treatment of adults with pulmonary arterial hypertension (PAH) to increase exercise capacity, improve World Health Organization (WHO) functional class (FC), and reduce the risk of clinical worsening events. Winrevair was previously granted breakthrough therapy designation by the FDA."
importance: ""
sourceUrl: "https://cardiovascularnews.com/winrevair-given-us-fda-approval-for-the-treatment-of-pulmonary-arterial-hypertension/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2024-03-28-winrevair-given-us-fda-approval-for-the-treatment-of-pulmonary-arterial-hypertension"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2024/03/WINREVAIR_60mg_kit.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/winrevair-given-us-fda-approval-for-the-treatment-of-pulmonary-arterial-hypertension/"
---

![Winrevair given US FDA approval for the treatment of pulmonary arterial hypertension](https://cardiovascularnews.com/wp-content/uploads/sites/14/2024/03/WINREVAIR_60mg_kit.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/winrevair-given-us-fda-approval-for-the-treatment-of-pulmonary-arterial-hypertension/*

## L’essentiel

Merck has announced the US Food and Drug Administration (FDA) has approved sotatercept-csrk (Winrevair) for the treatment of adults with pulmonary arterial hypertension (PAH) to increase exercise capacity, improve World Health Organization (WHO) functional class (FC), and reduce the risk of clinical worsening events. Winrevair was previously granted breakthrough therapy designation by the FDA.

## Lien source

https://cardiovascularnews.com/winrevair-given-us-fda-approval-for-the-treatment-of-pulmonary-arterial-hypertension/
